ResearcherOita UniversityActive in the last 2 years
Kazuhiro Tada
Matched on ORCID iD 0000-0002-6611-1059; OpenAlex author ID A5010862660. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma. First author DOI 10.3892/mco.2024.2813↗
- Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-021-02326-1↗
- Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-019-01953-z↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Teijiro Hirashita · 3 shared papers, 2020–2025 · strength 0.49
- Paper Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma. DOI 10.3892/mco.2024.2813↗
- Paper Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancre… DOI 10.1007/s00595-021-02326-1↗
- Paper Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma. DOI 10.1007/s00595-019-01953-z↗
- Masafumi Inomata · 3 shared papers, 2020–2025 · strength 0.49
- Paper Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma. DOI 10.3892/mco.2024.2813↗
- Paper Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancre… DOI 10.1007/s00595-021-02326-1↗
- Paper Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma. DOI 10.1007/s00595-019-01953-z↗
- Atsuro Fujinaga · 2 shared papers, 2022–2025 · strength 0.39
- Paper Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma. DOI 10.3892/mco.2024.2813↗
- Paper Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancre… DOI 10.1007/s00595-021-02326-1↗
- Yuiko Nagasawa · 1 shared paper, 2025 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.